Growth characteristics of human adenoviruses on porcine cell lines

Virology

Volumn 373, Issue 2, 2008, Pages 400-410

  Griesche, Nadine ^a   Zikos, Dimitrios ^a   Witkowski, Peter ^a   Nitsche, Andreas ^a   Ellerbrok, Heinz ^a   Brad Spiller, O ^b   Pauli, Georg ^a   Biere, Barbara ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adenoviridae; Recombinant vaccine; Xenotransplantation; Zoonosis

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR;

ADENOVIRUS; ADENOVIRUS 1; ADENOVIRUS 11; ADENOVIRUS 12; ADENOVIRUS 17; ADENOVIRUS 31; ADENOVIRUS 4; ADENOVIRUS 40; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL LINE; DISEASE PREDISPOSITION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIROGENESIS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TYPING; XENOTRANSPLANTATION; ZOONOSIS;

ADENOVIRUSES, HUMAN; ANIMALS; BASE SEQUENCE; CAPSID PROTEINS; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DNA, VIRAL; HELA CELLS; HUMANS; RECEPTORS, VIRUS; SEROTYPING; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION, HETEROLOGOUS; VIRULENCE; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS; SUS;

EID: 40849102809     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.12.015     Document Type: Article

References (49)

1. Adam M., Lepottier M.F., and Eloit M. Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies. Vet Microbiol. 42 2-3 (1994) 205-215
2. Adams D.H., Kadner A., Chen R.H., and Farivar R.S. Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates. Xenotranspl. 8 1 (2001) 36-40
3. Auchincloss Jr. H., and Sachs D.H. Xenogeneic transplantation. Annu. Rev. Immunol. 16 (1998) 433-470
4. Barsoum R.S. Parasitic infections in organ transplantation. Exp. Clin. Transpl. 2 2 (2004) 258-267
5. Betts A.O., Jennings A.R., Lamont P.H., and Page Z. Inoculation of pigs with adenoviruses of man. Nature 193 (1962) 45-46
6. Chmielewicz B., Nitsche A., Schweiger B., and Ellerbrok H. Development of a PCR-based assay for detection, quantification, and genotyping of human adenoviruses. Clin. Chem. 51 8 (2005) 1365-1373
7. Cohen C.J., Shieh J.T., Pickles R.J., Okegawa T., Hsieh J.T., and Bergelson J.M. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. U. S. A. 98 26 (2001) 15191-15196
8. Cozzi E., Tucker A.W., Langford G.A., Pino-Chavez G., Wright L., O'Connell M.J., Young V.J., Lancaster R., McLaughlin M., Hunt K., Bordin M.C., and White D.J. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 64 10 (1997) 1383-1392
9. Echavarria M., Forman M., Ticehurst J., Dumler J.S., and Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 36 11 (1998) 3323-3326
10. Echavarria M., Forman M., van Tol M.J., Vossen J.M., Charache P., and Kroes A.C. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 358 9279 (2001) 384-385
11. Fechner H., Haack A., Wang H., Wang X., Eizema K., Pauschinger M., Schoemaker R., Veghel R., Houtsmuller A., Schultheiss H.P., Lamers J., and Poller W. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther. 6 9 (1999) 1520-1535
12. Fishman J.A. Xenosis and xenotransplantation: addressing the infectious risks posed by an emerging technology. Kidney Int., Suppl. 58 (1997) S41-S45
13. Fishman J.A., and Patience C. Xenotransplantation: infectious risk revisited. Am. J. Transpl. 4 9 (2004) 1383-1390
14. Gaggar A., Shayakhmetov D.M., and Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9 11 (2003) 1408-1412
15. Guerin L.F., and Guerin M.M. Susceptibility of pig kidney tissue cultures to certain viruses. Proc. Soc. Exp. Biol. Med. 96 2 (1957) 322-323
16. Gunzburg W.H., and Salmons B. Xenotransplantation: is the risk of viral infection as great as we thought?. Mol. Med. Today 6 5 (2000) 199-208
17. Heim A., Ebnet C., Harste G., and Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70 2 (2003) 228-239
18. Hierholzer J.C. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5 3 (1992) 262-274
19. Jogler C., Hoffmann D., Theegarten D., Grunwald T., Uberla K., and Wildner O. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J. Virol. 80 7 (2006) 3549-3558
20. Jones M.S., Harrach B., Ganac R.D., Gozum M.M., Dela Cruz W.P., Riedel B., Pan C., Delwart E.L., and Schnurr D.P. New adenovirus species found in a patient presenting with gastroenteritis. J. Virol. 81 11 (2007) 5978-5984
21. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharmakol. 162 (1931) 956-959
22. Kirby I., Davison E., Beavil A.J., Soh C.P., Wickham T.J., Roelvink P.W., Kovesdi I., Sutton B.J., and Santis G. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J. Virol. 74 6 (2000) 2804-2813
23. Kumar D., and Humar A. Emerging viral infections in transplant recipients. Curr. Opin. Infect Dis. 18 4 (2005) 337-341
24. Lankester A.C., van Tol M.J., Claas E.C., Vossen J.M., and Kroes A.C. Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin. Infect. Dis. 34 6 (2002) 864-867
25. Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., Futterknecht B., Lawitschka A., Peters C., Potschger U., and Gadner H. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102 3 (2003) 1114-1120
26. Loveland B.E., Milland J., Kyriakou P., Thorley B.R., Christiansen D., Lanteri M.B., Regensburg M., Duffield M., French A.J., Williams L., Baker L., Brandon M.R., Xing P.X., Kahn D., and McKenzie I.F. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotranspl. 11 2 (2004) 171-183
27. Lucher L.A. Abortive adenovirus infection and host range determinants. Curr. Top. Microbiol. Immunol. 199 Pt 1 (1995) 119-152
28. Paradis K., Langford G., Long Z., Heneine W., Sandstrom P., Switzer W.M., Chapman L.E., Lockey C., Onions D., and Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue The XEN 111 Study Group. Science 285 5431 (1999) 1236-1241
29. Patience C., Takeuchi Y., and Weiss R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3 3 (1997) 282-286
30. Pham T.T., Burchette Jr. J.L., and Hale L.P. Fatal disseminated adenovirus infections in immunocompromised patients. Am. J. Clin. Pathol. 120 4 (2003) 575-583
31. Richardson C., Brennan P., Powell M., Prince S., Chen Y.H., Spiller O.B., and Rowe M. Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and alphavbeta5 integrin expression. J. Gen. Virol. 86 Pt 6 (2005) 1669-1679
32. Roelvink P.W., Lizonova A., Lee J.G., Li Y., Bergelson J.M., Finberg R.W., Brough D.E., Kovesdi I., and Wickham T.J. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A C, D, E, and F. J. Virol. 72 10 (1998) 7909-7915
33. Sachs D.H. The pig as a potential xenograft donor. Vet. Immunol. Immunopathol. 43 1-3 (1994) 185-191
34. Schilham M.W., Claas E.C., van Zaane W., Heemskerk B., Vossen J.M., Lankester A.C., Toes R.E., Echavarria M., Kroes A.C., and van Tol M.J. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin. Infect. Dis. 35 5 (2002) 526-532
35. Shayakhmetov D.M., Eberly A.M., Li Z.Y., and Lieber A. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J. Virol. 79 2 (2005) 1053-1061
36. Spearman C. The method of "right and wrong cases" (constant stimuli) without Gauss's formulae. Br. J. Psychol. 2 (1908) 227
37. Spiller O.B., Goodfellow I.G., Evans D.J., Hinchliffe S.J., and Morgan B.P. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF. J. Gen. Virol. 83 Pt 1 (2002) 45-52
38. Teramura T., Naya M., Yoshihara T., Kanoh G., Morimoto A., and Imashuku S. Adenoviral infection in hematopoietic stem cell transplantation: early diagnosis with quantitative detection of the viral genome in serum and urine. Bone Marrow Transplant. 33 1 (2004) 87-92
39. Torres J.M., Alonso C., Ortega A., Mittal S., Graham F., and Enjuanes L. Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol. 70 6 (1996) 3770-3780
40. Toyomura K., Fujimura T., Murakami H., Natsume T., Shigehisa T., Inoue N., Takeda J., and Kinoshita T. Molecular cloning of a pig homologue of membrane cofactor protein (CD46). Int. Immunol. 9 6 (1997) 869-876
41. van den Bogaerde J., and White D.J. Xenogeneic transplantation. Br. Med. Bull. 53(4) (1997) 904-920
42. van Kuppeveld F.J., Johansson K.E., Galama J.M., Kissing J., Bolske G., van der Logt J.T., and Melchers W.J. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl. Environ. Microbiol. 60 1 (1994) 149-152
43. Venkatesan P., Perfect J.R., and Myers S.A. Evaluation and management of fungal infections in immunocompromised patients. Dermatol. Ther. 18 1 (2005) 44-57
44. Walls T., Shankar A.G., and Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet, Infect. Dis. 3 2 (2003) 79-86
45. Wesley R.D., and Lager K.M. Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus. Am. J. Vet. Res. 66 11 (2005) 1943-1947
46. Yoo D., and Giulivi A. Xenotransplantation and the potential risk of xenogeneic transmission of porcine viruses. Can. J. Vet. Res. 64 4 (2000) 193-203
47. Yoshikawa T. Significance of human herpesviruses to transplant recipients. Curr. Opin. Infect Dis. 16 6 (2003) 601-606
48. Zhang Y., and Bergelson J.M. Adenovirus receptors. J. Virol. 79 19 (2005) 12125-12131
49. Zhou C.Y., McInnes E., Copeman L., Langford G., Parsons N., Lancaster R., Richards A., Carrington C., and Thompson S. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor. Xenotranspl. 12 2 (2005) 142-148